Accordingly, patients with acromegaly, who have high GH plasma levels, show a higher incidence of cancer [80,81], while patients with Laron syndrome who are resistant to GH due to a defective GHR and patients with GH deficiency have reduced cancer susceptibility [82,83]. The gene discussed is GH1; the disease is cancer.